Biochip platforms that work as artificial cells are attractive for medical diagnostics, interrogation of biological processes, and for the production of important biomolecules. In a major breakthrough, a group of researchers at the Weizmann Institute of Science in Israel, led by Roy Bar-Ziv, have designed a molecule affectionately called the "daisy" that is able to bind genes onto chips in miniature patterned arrays.
Lees meer...
Bron: ScienceDaily Headlines
Daily headlines about discoveries in the physical and life sciences, health and medicine, the environment, and technology, from the world's leading universities and research centers.